Patent intelligence · US
US 8466267
Nucleic acid encoding a zinc finger that recognizes the sodium channel Nav 1.8 (PN3) gene
Nucleic acid encoding a zinc finger that recognizes the sodium channel Nav 1.8 (PN3) gene
Patent details — US 8466267
- Jurisdiction
- US
- Status
- granted
- Grant date
- Jun 18, 2013
- Expiration
- Jun 13, 2033
- Applicant
- Sangamo Biosciences, Inc.
- Claims
- 5
- CPC classes
- A61K, A61K38/17, A61K48/00, A61P
Quick answer
US 8466267 (Nucleic acid encoding a zinc finger that recognizes the sodium channel Nav 1.8 (PN3) gene) is held by Sangamo Biosciences, Inc.. Status: granted. Granted Jun 18, 2013. Expires Jun 13, 2033 (7 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- Sangamo Biosciences, Inc.
- Grant date
- Expiration
- Claims
- 5
- CPC classes
- A61K, A61K38/17, A61K48/00, A61P, A61P25/00, A61P25/02
More from Sangamo Biosciences, Inc.
Related pharmaceutical patents in our USPTO index.
-
US 12318427
Methods and compositions for modulation of tau proteins
granted -
US 12139517
Modulators of chromosome 9 open reading frame 72 gene expression and uses thereof
granted -
US 12043650
Methods and compositions for modification of a cystic fibrosis transmembrane conductance regulator (CFTR) gene
granted -
US 11981967
Engineering AAV
granted -
US 11981739
Chimeric antigen receptor specific for interleukin-23 receptor
granted -
US 11920169
Compositions for linking DNA-binding domains and cleavage domains
granted -
US 11898158
Methods and compositions for the treatment of lysosomal storage diseases
granted -
US 11884930
Method of inactivating a glucocorticoid receptor gene in an isolated cell
granted
Frequently asked questions
What is US patent 8466267?
US 8466267 (Nucleic acid encoding a zinc finger that recognizes the sodium channel Nav 1.8 (PN3) gene) is held by Sangamo Biosciences, Inc.. Status: granted. Granted Jun 18, 2013. Expires Jun 13, 2033 (7 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 8466267?
Sangamo Biosciences, Inc. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 192 pharmaceutical patents for this assignee.
When does US 8466267 expire?
Our index shows an expiration date of Jun 13, 2033 (7 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.